Dr. Lina Williamson is a translational scientist and biotech entrepreneur with deep expertise in dermatology, allergy, and translational medicine. At Novartis, she served as Director of Strategy and Operations for Academic Outreach at the Novartis Institutes for Biomedical Research, leading global innovation sourcing from top academic medical centers to support from discovery to translational medicine across all therapeutic areas. She later joined the Wyss Institute at Harvard, where she contributed to the launch of Emulate and co-invented the Skin-on-Chip platform.

Lina played a key role in digital transformation and translational research at Hospital Clínic de Barcelona, and previously advanced early clinical development to startup formation at Brigham and Women’s Hospital, where she spearheaded efforts to increase the value of intellectual property through the Translational Medicine Accelerator. She is currently Co-founder and Executive Director of Soterya, a Brigham spin-off, developing an intelligent body repositioning system (smart bed) to prevent pressure injuries, support mobility, and improve sleep quality. As a Research Fellow at MIT Catalyst and the VA, she is also developing novel care solutions for veterans with spinal cord injuries to prevent pressure-related complications. Besides Soterya, Lina is also Co-founder of TMA Precision Health and Adaptive Biotechnologies, where she continues to shape innovation strategy at the intersection of data, technology, and patient care.